XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Oct. 31, 2020
Oct. 31, 2019
Oct. 31, 2020
Oct. 31, 2019
Income Statement [Abstract]        
Net sales $ 39,000 $ 39,722 $ 75,423 $ 79,058
Cost of products sold 32,605 33,406 63,147 65,796
Gross profit 6,395 6,316 12,276 13,262
Operating expenses 6,406 6,355 12,563 12,525
Operating earnings (loss) (11) (39) (287) 737
Pension expense (289) (113) (577) (226)
Other income 66 129 120 298
Interest expense (128) (135) (205) (302)
Earnings (loss) before income taxes (362) (158) (949) 507
Income tax expense (benefit) (197) 2,003 (176) 2,172
Net loss (165) (2,161) (773) (1,665)
Less: net earnings attributable to the noncontrolling interest 15 17 5 42
Net loss attributable to Kewaunee Scientific Corporation $ (180) $ (2,178) $ (778) $ (1,707)
Net loss per share attributable to Kewaunee Scientific Corporation stockholders        
Basic (in dollars per share) $ (0.07) $ (0.79) $ (0.28) $ (0.62)
Diluted (in dollars per share) $ (0.07) $ (0.79) $ (0.28) $ (0.62)
Weighted average number of common shares outstanding        
Basic 2,759 2,750 2,757 2,750
Diluted 2,759 2,750 2,757 2,750